Michael Page

Title: Michael Page - Innovator in Membrane-Interacting Peptides

Introduction

Michael Page is a distinguished inventor based in Oakland, CA. He has made significant contributions to the field of biochemistry, particularly in the development of activatable membrane-interacting peptides. With a total of 3 patents, his work has the potential to impact various medical applications.

Latest Patents

One of Michael Page's latest patents focuses on activatable membrane-interacting peptides and their methods of use. This patent describes compounds that can interact with phospholipid bilayers, such as cell membranes, following activation. The compounds are structured as X-A-X-Z-X, where A is a membrane-interacting peptide region, Z is an inhibitory peptide region, and X represents a cleavable linker. These compositions can be utilized in methods such as directly imaging active clotting within a subject, showcasing their versatility and potential in medical diagnostics.

Career Highlights

Michael Page is affiliated with the University of California, where he continues to advance his research in peptide technology. His innovative work has garnered attention in the scientific community, contributing to the understanding of membrane interactions at a molecular level.

Collaborations

Michael collaborates with Charles S Craik, a fellow researcher who shares his passion for biochemistry and peptide research. Their combined expertise enhances the potential for groundbreaking discoveries in their field.

Conclusion

Michael Page's contributions to the development of activatable membrane-interacting peptides highlight his role as a leading inventor in biochemistry. His innovative patents and collaborations pave the way for advancements in medical applications and diagnostics.